Key Releases are ad hoc announcements pursuant to SIX Swiss Exchange Article 53 Listing Rules.
Header
News Archive
News Archive Navigation
icon
News Archive Navigation Language
Language Preferences
Showing 385 results
February 2016
-
Opening chemistry education to the world
Novartis taps MOOC technology to share chemistry education with the world
-
Neuroscientists restore cell-to-cell signaling and sociability in autism models
Team uncovers a potential therapeutic approach for patients deficient in a protein called Shank3.
-
Novartis and Pfizer join forces to upend oncology dogma
Industry labs find that, contrary to earlier evidence, KRAS-driven tumors are not addicted to autophagy.
January 2016
-
Rare speed on a rare disease
An investigational treatment for an uncommon immunodeficiency disease races into clinical studies.
-
How to address the culture gap between academia and industry in biomedicine
Experts call for significant changes to facilitate the discovery of new treatments.
November 2015
-
Bringing modern medicine to rural Vietnam
Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam to combat a rise in chronic diseases such as diabetes, hypertension and respiratory ailments.
-
Giraffes have high blood pressure. Why don’t they drop dead?
A certain leggy resident of the African grasslands is arousing a lot of interest among evolutionary biologists. They believe that study of giraffes' unique features could lead the way to advances in human health.
October 2015
-
Stepping toward regenerative medicine for diabetes
Discovery points toward treatment options beyond insulin injections
-
Compounds spur insulin-producing cells to replicate in the lab
-
Clinical trials make a move toward mice
By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs
-
Delivering access: first launch in Kenya
Chronic diseases kill 38 million people per year worldwide; almost three-quarters of those deaths occur in low- and middle-income countries. It’s time to act.
-
Getting down to the roots of Alzheimer’s disease
Experimental treatments for Alzheimer’s disease put the amyloid cascade hypothesis to the test.
Pagination
- ‹ Previous page
- 1
- …
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- …
- 33
- › Next page